Form 8-K Surgery Partners, Inc. For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
November 13, 2024 4:03 PM ESTJefferies analyst Brian Tanquilut lowered the price target on Surgery Partners (NASDAQ: SGRY) to $40.00 (from $47.00) while maintaining a Buy rating.
The analyst comments "Our takes post-Q3 release/call: 1) some of the stock's weakness is due to rotation out by... More
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
November 13, 2024 9:44 AM ESTBarclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a Equalweight rating.
The analyst comments "Free Cash Flow: SGRY has delivered about $36 mn free cash flow YTD, representing about 25% of the informal 2024 target... More



